Evidence map›Paper›PMID 39614902›Full record

ArticlePediatric nephrology (Berlin, Germany)2025

Evaluation of predictive performance of fetal urinary inflammatory markers of postnatal kidney function in fetuses with posterior urethral valves.

Nicolas Geraud, Audrey Casemayou, Melinda Alves, Benjamin Breuil, Marcin Tkaczyk, Małgorzata Stańczyk, Krzysztof Szaflik, Tomasz Talar, Stéphane Decramer, Julie Klein and 2 more

Abstract read
In one paragraph

Article in Pediatric nephrology (Berlin, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Prenatal body fluid analysis in the evaluation of CAKUT.Pediatric nephrology (Berlin, Germany) · 2026
    Review
  2. Review
  3. Article
  4. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nicolas GeraudNational Institute of Health and Medical Research (INSERM), UMR 1297, Institute of Metabolic and Cardiovascular Disease, Toulouse, France.
Audrey CasemayouNational Institute of Health and Medical Research (INSERM), UMR 1297, Institute of Metabolic and Cardiovascular Disease, Toulouse, France.
Melinda AlvesNational Institute of Health and Medical Research (INSERM), UMR 1297, Institute of Metabolic and Cardiovascular Disease, Toulouse, France.
Benjamin BreuilNational Institute of Health and Medical Research (INSERM), UMR 1297, Institute of Metabolic and Cardiovascular Disease, Toulouse, France.
Marcin TkaczykDepartment of Pediatric, Immunology and Nephrology, Polish Mother's Memorial Hospital Research Institute, Łódź, Poland.
Małgorzata StańczykDepartment of Pediatric, Immunology and Nephrology, Polish Mother's Memorial Hospital Research Institute, Łódź, Poland.
Krzysztof SzaflikDepartment of Gynecology, Fertility and Fetal Therapy, Polish Mother's Memorial Hospital Research Institute, Łódź, Poland.
Tomasz TalarDepartment of Neonatology and Intensive Therapy, Polish Mother's Memorial Hospital Research Institute, Łódź, Poland.
Stéphane DecramerNational Institute of Health and Medical Research (INSERM), UMR 1297, Institute of Metabolic and Cardiovascular Disease, Toulouse, France.
Julie KleinNational Institute of Health and Medical Research (INSERM), UMR 1297, Institute of Metabolic and Cardiovascular Disease, Toulouse, France.
Joost P SchanstraNational Institute of Health and Medical Research (INSERM), UMR 1297, Institute of Metabolic and Cardiovascular Disease, Toulouse, France. joost-peter.schanstra@inserm.fr.ORCID http://orcid.org/0000-0002-7471-372X
Bénédicte Buffin MeyerNational Institute of Health and Medical Research (INSERM), UMR 1297, Institute of Metabolic and Cardiovascular Disease, Toulouse, France.

Funding

Agence de la biomedicine METAPhORAgence Nationale de la Recherche ANR-10-INBS-04FRM DEQ20170336759PHRC N° 10 138 01 - N° RCB 2010-AO1151-38
6 · The paper itself

Abstract

backgroundThere are proposed roles for inflammation in the development of congenital obstructive uropathy in the setting of posterior urethral valves (PUV). However, the value of inflammatory proteins as predictive markers of postnatal kidney function, key in the management of fetuses with PUV, has not been explored. We screened fetal urine of fetuses with PUV with a panel of inflammatory proteins to determine their predictive value of postnatal kidney function.

methodsTwenty-five different chemokines and cytokines were measured using a multiplex immunoassay in fetal urine of 79 PUV patients from retrospective cohorts, separated in discovery (n = 52) and validation (n = 27). The candidate markers were also quantified in amniotic fluid samples obtained from 16 PUV and 25 other congenital anomalies of the kidney and the urinary tract pregnancies. The performance of validated candidate inflammatory proteins was compared to the previously published 12PUV fetal urine peptide signature.

resultsFetal urine chemokines CCL2 (MCP-1), CXCL9 (MIG), and CCL4 (MIP-1β) were identified as predictive of postnatal kidney failure in fetuses with PUV from the discovery cohort. Their predictive potential was confirmed in the validation cohort (AUCs of 0.87, 0.81, and 0.86, respectively). The performance of these individual chemokines was lower than the previously published 12PUV fetal urine peptide signature. However, the combination of the three chemokines performed similarly to 12PUV. In contrast, these three chemokines were not predictive of outcome in amniotic fluid.

conclusionsWe identified chemokines in fetal urine of PUV pregnancies that, after external validation, could serve as predictive biomarkers of postnatal outcome and contribute to improve prenatal PUV management.

Indexed as

KidneyUrethraUrethral ObstructionAmniotic FluidBiomarkersChemokine CCL2ChemokinesFemaleHumansInfant, NewbornPredictive Value of TestsPregnancyPrenatal DiagnosisRetrospective StudiesBiomarkersCCL2 protein, humanChemokine CCL2ChemokinesBiomarkerBody fluidsInflammationKidney functionOutcomePrenatal diagnosis

Identifiers

PMID39614902
PMCPMC11885327

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.